 | • レポートコード：GIR201109952 • 出版社/出版日：GlobalInfoResearch / 2020年10月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール • 産業分類：医薬品・医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、腫瘍壊死因子受容体スーパーファミリーメンバー9の世界市場を調査対象にし、腫瘍壊死因子受容体スーパーファミリーメンバー9の市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（Ultra-41BBL、PRS-342、ISAS-01、EU-101、その他）、用途別分析（胃がん、膀胱がん、子宮頸がん、リンパ腫、その他）、市場予測（2021年～2025年）、販売チャンネル・代理店分析情報などを整理しました。 ・市場概要 ・メーカー情報：Agenus Inc、Pfizer Inc、BioInvent International AB、Alligator Bioscience AB、MacroGenics Inc、Apogenix GmbH、Juno Therapeutics Inc、Eli Lilly and Co、Pieris Pharmaceuticals Inc ・メーカー別販売量、売上、市場シェア ・腫瘍壊死因子受容体スーパーファミリーメンバー9の地域別市場分析 ・腫瘍壊死因子受容体スーパーファミリーメンバー9の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・腫瘍壊死因子受容体スーパーファミリーメンバー9のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・腫瘍壊死因子受容体スーパーファミリーメンバー9のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・腫瘍壊死因子受容体スーパーファミリーメンバー9の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・腫瘍壊死因子受容体スーパーファミリーメンバー9の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・腫瘍壊死因子受容体スーパーファミリーメンバー9の種類別市場規模2015-2020：Ultra-41BBL、PRS-342、ISAS-01、EU-101、その他 ・腫瘍壊死因子受容体スーパーファミリーメンバー9の用途別市場規模2015-2020：胃がん、膀胱がん、子宮頸がん、リンパ腫、その他 ・腫瘍壊死因子受容体スーパーファミリーメンバー9の世界市場予測2021-2025：地域別、種類別、用途別 ・販売チャンネル・代理店分析 ・調査の結果・結論 |
Market Overview
The global Tumor Necrosis Factor Receptor Superfamily Member 9 market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Tumor Necrosis Factor Receptor Superfamily Member 9 market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Tumor Necrosis Factor Receptor Superfamily Member 9 market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Tumor Necrosis Factor Receptor Superfamily Member 9 market has been segmented into
Ultra-41BBL
PRS-342
ISAS-01
EU-101
Others
By Application, Tumor Necrosis Factor Receptor Superfamily Member 9 has been segmented into:
Gastric Cancer
Bladder Cancer
Cervical Cancer
Lymphoma
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Tumor Necrosis Factor Receptor Superfamily Member 9 market presented in the report. This section sheds light on the sales growth of different regional and country-level Tumor Necrosis Factor Receptor Superfamily Member 9 markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Tumor Necrosis Factor Receptor Superfamily Member 9 market.
The report offers in-depth assessment of the growth and other aspects of the Tumor Necrosis Factor Receptor Superfamily Member 9 market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Tumor Necrosis Factor Receptor Superfamily Member 9 Market Share Analysis
Tumor Necrosis Factor Receptor Superfamily Member 9 competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Tumor Necrosis Factor Receptor Superfamily Member 9 sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Tumor Necrosis Factor Receptor Superfamily Member 9 sales, revenue and market share for each player covered in this report.
The major players covered in Tumor Necrosis Factor Receptor Superfamily Member 9 are:
Agenus Inc
Pfizer Inc
BioInvent International AB
Alligator Bioscience AB
MacroGenics Inc
Apogenix GmbH
Juno Therapeutics Inc
Eli Lilly and Co
Pieris Pharmaceuticals Inc
Among other players domestic and global, Tumor Necrosis Factor Receptor Superfamily Member 9 market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Tumor Necrosis Factor Receptor Superfamily Member 9 product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Tumor Necrosis Factor Receptor Superfamily Member 9, with price, sales, revenue and global market share of Tumor Necrosis Factor Receptor Superfamily Member 9 in 2018 and 2019.
Chapter 3, the Tumor Necrosis Factor Receptor Superfamily Member 9 competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Tumor Necrosis Factor Receptor Superfamily Member 9 breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Tumor Necrosis Factor Receptor Superfamily Member 9 market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Tumor Necrosis Factor Receptor Superfamily Member 9 sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Tumor Necrosis Factor Receptor Superfamily Member 9 Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Tumor Necrosis Factor Receptor Superfamily Member 9 Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Ultra-41BBL
1.2.3 PRS-342
1.2.4 ISAS-01
1.2.5 EU-101
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Tumor Necrosis Factor Receptor Superfamily Member 9 Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Gastric Cancer
1.3.3 Bladder Cancer
1.3.4 Cervical Cancer
1.3.5 Lymphoma
1.3.6 Others
1.4 Overview of Global Tumor Necrosis Factor Receptor Superfamily Member 9 Market
1.4.1 Global Tumor Necrosis Factor Receptor Superfamily Member 9 Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Agenus Inc
2.1.1 Agenus Inc Details
2.1.2 Agenus Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Agenus Inc SWOT Analysis
2.1.4 Agenus Inc Product and Services
2.1.5 Agenus Inc Tumor Necrosis Factor Receptor Superfamily Member 9 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Pfizer Inc
2.2.1 Pfizer Inc Details
2.2.2 Pfizer Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Pfizer Inc SWOT Analysis
2.2.4 Pfizer Inc Product and Services
2.2.5 Pfizer Inc Tumor Necrosis Factor Receptor Superfamily Member 9 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 BioInvent International AB
2.3.1 BioInvent International AB Details
2.3.2 BioInvent International AB Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 BioInvent International AB SWOT Analysis
2.3.4 BioInvent International AB Product and Services
2.3.5 BioInvent International AB Tumor Necrosis Factor Receptor Superfamily Member 9 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Alligator Bioscience AB
2.4.1 Alligator Bioscience AB Details
2.4.2 Alligator Bioscience AB Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Alligator Bioscience AB SWOT Analysis
2.4.4 Alligator Bioscience AB Product and Services
2.4.5 Alligator Bioscience AB Tumor Necrosis Factor Receptor Superfamily Member 9 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 MacroGenics Inc
2.5.1 MacroGenics Inc Details
2.5.2 MacroGenics Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 MacroGenics Inc SWOT Analysis
2.5.4 MacroGenics Inc Product and Services
2.5.5 MacroGenics Inc Tumor Necrosis Factor Receptor Superfamily Member 9 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Apogenix GmbH
2.6.1 Apogenix GmbH Details
2.6.2 Apogenix GmbH Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Apogenix GmbH SWOT Analysis
2.6.4 Apogenix GmbH Product and Services
2.6.5 Apogenix GmbH Tumor Necrosis Factor Receptor Superfamily Member 9 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Juno Therapeutics Inc
2.7.1 Juno Therapeutics Inc Details
2.7.2 Juno Therapeutics Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Juno Therapeutics Inc SWOT Analysis
2.7.4 Juno Therapeutics Inc Product and Services
2.7.5 Juno Therapeutics Inc Tumor Necrosis Factor Receptor Superfamily Member 9 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Eli Lilly and Co
2.8.1 Eli Lilly and Co Details
2.8.2 Eli Lilly and Co Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Eli Lilly and Co SWOT Analysis
2.8.4 Eli Lilly and Co Product and Services
2.8.5 Eli Lilly and Co Tumor Necrosis Factor Receptor Superfamily Member 9 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Pieris Pharmaceuticals Inc
2.9.1 Pieris Pharmaceuticals Inc Details
2.9.2 Pieris Pharmaceuticals Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Pieris Pharmaceuticals Inc SWOT Analysis
2.9.4 Pieris Pharmaceuticals Inc Product and Services
2.9.5 Pieris Pharmaceuticals Inc Tumor Necrosis Factor Receptor Superfamily Member 9 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Tumor Necrosis Factor Receptor Superfamily Member 9 Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Tumor Necrosis Factor Receptor Superfamily Member 9 Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Tumor Necrosis Factor Receptor Superfamily Member 9 Manufacturer Market Share in 2019
3.3.2 Top 6 Tumor Necrosis Factor Receptor Superfamily Member 9 Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Tumor Necrosis Factor Receptor Superfamily Member 9 Sales, Revenue and Market Share by Regions
4.1.1 Global Tumor Necrosis Factor Receptor Superfamily Member 9 Sales and Market Share by Regions (2015-2020)
4.1.2 Global Tumor Necrosis Factor Receptor Superfamily Member 9 Revenue and Market Share by Regions (2015-2020)
4.2 North America Tumor Necrosis Factor Receptor Superfamily Member 9 Sales and Growth Rate (2015-2020)
4.3 Europe Tumor Necrosis Factor Receptor Superfamily Member 9 Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Tumor Necrosis Factor Receptor Superfamily Member 9 Sales and Growth Rate (2015-2020)
4.5 South America Tumor Necrosis Factor Receptor Superfamily Member 9 Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Tumor Necrosis Factor Receptor Superfamily Member 9 Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Tumor Necrosis Factor Receptor Superfamily Member 9 Sales, Revenue and Market Share by Country
5.1.1 North America Tumor Necrosis Factor Receptor Superfamily Member 9 Sales and Market Share by Country (2015-2020)
5.1.2 North America Tumor Necrosis Factor Receptor Superfamily Member 9 Revenue and Market Share by Country (2015-2020)
5.2 United States Tumor Necrosis Factor Receptor Superfamily Member 9 Sales and Growth Rate (2015-2020)
5.3 Canada Tumor Necrosis Factor Receptor Superfamily Member 9 Sales and Growth Rate (2015-2020)
5.4 Mexico Tumor Necrosis Factor Receptor Superfamily Member 9 Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Tumor Necrosis Factor Receptor Superfamily Member 9 Sales, Revenue and Market Share by Country
6.1.1 Europe Tumor Necrosis Factor Receptor Superfamily Member 9 Sales and Market Share by Country (2015-2020)
6.1.2 Europe Tumor Necrosis Factor Receptor Superfamily Member 9 Revenue and Market Share by Country (2015-2020)
6.2 Germany Tumor Necrosis Factor Receptor Superfamily Member 9 Sales and Growth Rate (2015-2020)
6.3 UK Tumor Necrosis Factor Receptor Superfamily Member 9 Sales and Growth Rate (2015-2020)
6.4 France Tumor Necrosis Factor Receptor Superfamily Member 9 Sales and Growth Rate (2015-2020)
6.5 Russia Tumor Necrosis Factor Receptor Superfamily Member 9 Sales and Growth Rate (2015-2020)
6.6 Italy Tumor Necrosis Factor Receptor Superfamily Member 9 Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Tumor Necrosis Factor Receptor Superfamily Member 9 Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Tumor Necrosis Factor Receptor Superfamily Member 9 Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Tumor Necrosis Factor Receptor Superfamily Member 9 Revenue and Market Share by Regions (2015-2020)
7.2 China Tumor Necrosis Factor Receptor Superfamily Member 9 Sales and Growth Rate (2015-2020)
7.3 Japan Tumor Necrosis Factor Receptor Superfamily Member 9 Sales and Growth Rate (2015-2020)
7.4 Korea Tumor Necrosis Factor Receptor Superfamily Member 9 Sales and Growth Rate (2015-2020)
7.5 India Tumor Necrosis Factor Receptor Superfamily Member 9 Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Tumor Necrosis Factor Receptor Superfamily Member 9 Sales and Growth Rate (2015-2020)
7.7 Australia Tumor Necrosis Factor Receptor Superfamily Member 9 Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Tumor Necrosis Factor Receptor Superfamily Member 9 Sales, Revenue and Market Share by Country
8.1.1 South America Tumor Necrosis Factor Receptor Superfamily Member 9 Sales and Market Share by Country (2015-2020)
8.1.2 South America Tumor Necrosis Factor Receptor Superfamily Member 9 Revenue and Market Share by Country (2015-2020)
8.2 Brazil Tumor Necrosis Factor Receptor Superfamily Member 9 Sales and Growth Rate (2015-2020)
8.3 Argentina Tumor Necrosis Factor Receptor Superfamily Member 9 Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Tumor Necrosis Factor Receptor Superfamily Member 9 Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Tumor Necrosis Factor Receptor Superfamily Member 9 Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Tumor Necrosis Factor Receptor Superfamily Member 9 Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Tumor Necrosis Factor Receptor Superfamily Member 9 Sales and Growth Rate (2015-2020)
9.3 Turkey Tumor Necrosis Factor Receptor Superfamily Member 9 Sales and Growth Rate (2015-2020)
9.4 Egypt Tumor Necrosis Factor Receptor Superfamily Member 9 Sales and Growth Rate (2015-2020)
9.5 South Africa Tumor Necrosis Factor Receptor Superfamily Member 9 Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Tumor Necrosis Factor Receptor Superfamily Member 9 Sales and Market Share by Type (2015-2020)
10.2 Global Tumor Necrosis Factor Receptor Superfamily Member 9 Revenue and Market Share by Type (2015-2020)
10.3 Global Tumor Necrosis Factor Receptor Superfamily Member 9 Price by Type (2015-2020)
11 Global Tumor Necrosis Factor Receptor Superfamily Member 9 Market Segment by Application
11.1 Global Tumor Necrosis Factor Receptor Superfamily Member 9 Sales Market Share by Application (2015-2020)
11.2 Global Tumor Necrosis Factor Receptor Superfamily Member 9 Revenue Market Share by Application (2015-2020)
11.3 Global Tumor Necrosis Factor Receptor Superfamily Member 9 Price by Application (2015-2020)
12 Market Forecast
12.1 Global Tumor Necrosis Factor Receptor Superfamily Member 9 Sales, Revenue and Growth Rate (2021-2025)
12.2 Tumor Necrosis Factor Receptor Superfamily Member 9 Market Forecast by Regions (2021-2025)
12.2.1 North America Tumor Necrosis Factor Receptor Superfamily Member 9 Market Forecast (2021-2025)
12.2.2 Europe Tumor Necrosis Factor Receptor Superfamily Member 9 Market Forecast (2021-2025)
12.2.3 Asia-Pacific Tumor Necrosis Factor Receptor Superfamily Member 9 Market Forecast (2021-2025)
12.2.4 South America Tumor Necrosis Factor Receptor Superfamily Member 9 Market Forecast (2021-2025)
12.2.5 Middle East & Africa Tumor Necrosis Factor Receptor Superfamily Member 9 Market Forecast (2021-2025)
12.3 Tumor Necrosis Factor Receptor Superfamily Member 9 Market Forecast by Type (2021-2025)
12.3.1 Global Tumor Necrosis Factor Receptor Superfamily Member 9 Sales Forecast by Type (2021-2025)
12.3.2 Global Tumor Necrosis Factor Receptor Superfamily Member 9 Market Share Forecast by Type (2021-2025)
12.4 Tumor Necrosis Factor Receptor Superfamily Member 9 Market Forecast by Application (2021-2025)
12.4.1 Global Tumor Necrosis Factor Receptor Superfamily Member 9 Sales Forecast by Application (2021-2025)
12.4.2 Global Tumor Necrosis Factor Receptor Superfamily Member 9 Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Tumor Necrosis Factor Receptor Superfamily Member 9 Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Tumor Necrosis Factor Receptor Superfamily Member 9 by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Tumor Necrosis Factor Receptor Superfamily Member 9 Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Agenus Inc Basic Information, Manufacturing Base and Competitors
Table 8. Agenus Inc Tumor Necrosis Factor Receptor Superfamily Member 9 Major Business
Table 9. Agenus Inc Tumor Necrosis Factor Receptor Superfamily Member 9 Total Revenue (USD Million) (2018-2019)
Table 10. Agenus Inc SWOT Analysis
Table 11. Agenus Inc Tumor Necrosis Factor Receptor Superfamily Member 9 Product and Services
Table 12. Agenus Inc Tumor Necrosis Factor Receptor Superfamily Member 9 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Pfizer Inc Basic Information, Manufacturing Base and Competitors
Table 14. Pfizer Inc Tumor Necrosis Factor Receptor Superfamily Member 9 Major Business
Table 15. Pfizer Inc Tumor Necrosis Factor Receptor Superfamily Member 9 Total Revenue (USD Million) (2018-2019)
Table 16. Pfizer Inc SWOT Analysis
Table 17. Pfizer Inc Tumor Necrosis Factor Receptor Superfamily Member 9 Product and Services
Table 18. Pfizer Inc Tumor Necrosis Factor Receptor Superfamily Member 9 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. BioInvent International AB Basic Information, Manufacturing Base and Competitors
Table 20. BioInvent International AB Tumor Necrosis Factor Receptor Superfamily Member 9 Major Business
Table 21. BioInvent International AB Tumor Necrosis Factor Receptor Superfamily Member 9 Total Revenue (USD Million) (2018-2019)
Table 22. BioInvent International AB SWOT Analysis
Table 23. BioInvent International AB Tumor Necrosis Factor Receptor Superfamily Member 9 Product and Services
Table 24. BioInvent International AB Tumor Necrosis Factor Receptor Superfamily Member 9 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Alligator Bioscience AB Basic Information, Manufacturing Base and Competitors
Table 26. Alligator Bioscience AB Tumor Necrosis Factor Receptor Superfamily Member 9 Major Business
Table 27. Alligator Bioscience AB Tumor Necrosis Factor Receptor Superfamily Member 9 Total Revenue (USD Million) (2018-2019)
Table 28. Alligator Bioscience AB SWOT Analysis
Table 29. Alligator Bioscience AB Tumor Necrosis Factor Receptor Superfamily Member 9 Product and Services
Table 30. Alligator Bioscience AB Tumor Necrosis Factor Receptor Superfamily Member 9 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. MacroGenics Inc Basic Information, Manufacturing Base and Competitors
Table 32. MacroGenics Inc Tumor Necrosis Factor Receptor Superfamily Member 9 Major Business
Table 33. MacroGenics Inc Tumor Necrosis Factor Receptor Superfamily Member 9 Total Revenue (USD Million) (2018-2019)
Table 34. MacroGenics Inc SWOT Analysis
Table 35. MacroGenics Inc Tumor Necrosis Factor Receptor Superfamily Member 9 Product and Services
Table 36. MacroGenics Inc Tumor Necrosis Factor Receptor Superfamily Member 9 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Apogenix GmbH Basic Information, Manufacturing Base and Competitors
Table 38. Apogenix GmbH Tumor Necrosis Factor Receptor Superfamily Member 9 Major Business
Table 39. Apogenix GmbH Tumor Necrosis Factor Receptor Superfamily Member 9 Total Revenue (USD Million) (2018-2019)
Table 40. Apogenix GmbH SWOT Analysis
Table 41. Apogenix GmbH Tumor Necrosis Factor Receptor Superfamily Member 9 Product and Services
Table 42. Apogenix GmbH Tumor Necrosis Factor Receptor Superfamily Member 9 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Juno Therapeutics Inc Basic Information, Manufacturing Base and Competitors
Table 44. Juno Therapeutics Inc Tumor Necrosis Factor Receptor Superfamily Member 9 Major Business
Table 45. Juno Therapeutics Inc Tumor Necrosis Factor Receptor Superfamily Member 9 Total Revenue (USD Million) (2018-2019)
Table 46. Juno Therapeutics Inc SWOT Analysis
Table 47. Juno Therapeutics Inc Tumor Necrosis Factor Receptor Superfamily Member 9 Product and Services
Table 48. Juno Therapeutics Inc Tumor Necrosis Factor Receptor Superfamily Member 9 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Eli Lilly and Co Basic Information, Manufacturing Base and Competitors
Table 50. Eli Lilly and Co Tumor Necrosis Factor Receptor Superfamily Member 9 Major Business
Table 51. Eli Lilly and Co Tumor Necrosis Factor Receptor Superfamily Member 9 Total Revenue (USD Million) (2018-2019)
Table 52. Eli Lilly and Co SWOT Analysis
Table 53. Eli Lilly and Co Tumor Necrosis Factor Receptor Superfamily Member 9 Product and Services
Table 54. Eli Lilly and Co Tumor Necrosis Factor Receptor Superfamily Member 9 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Pieris Pharmaceuticals Inc Basic Information, Manufacturing Base and Competitors
Table 56. Pieris Pharmaceuticals Inc Tumor Necrosis Factor Receptor Superfamily Member 9 Major Business
Table 57. Pieris Pharmaceuticals Inc Tumor Necrosis Factor Receptor Superfamily Member 9 Total Revenue (USD Million) (2018-2019)
Table 58. Pieris Pharmaceuticals Inc SWOT Analysis
Table 59. Pieris Pharmaceuticals Inc Tumor Necrosis Factor Receptor Superfamily Member 9 Product and Services
Table 60. Pieris Pharmaceuticals Inc Tumor Necrosis Factor Receptor Superfamily Member 9 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Global Tumor Necrosis Factor Receptor Superfamily Member 9 Sales by Manufacturer (2018-2019) (K Pcs)
Table 62. Global Tumor Necrosis Factor Receptor Superfamily Member 9 Revenue by Manufacturer (2018-2019) (USD Million)
Table 63. Global Tumor Necrosis Factor Receptor Superfamily Member 9 Sales by Regions (2015-2020) (K Pcs)
Table 64. Global Tumor Necrosis Factor Receptor Superfamily Member 9 Sales Market Share by Regions (2015-2020)
Table 65. Global Tumor Necrosis Factor Receptor Superfamily Member 9 Revenue by Regions (2015-2020) (USD Million)
Table 66. North America Tumor Necrosis Factor Receptor Superfamily Member 9 Sales by Countries (2015-2020) (K Pcs)
Table 67. North America Tumor Necrosis Factor Receptor Superfamily Member 9 Sales Market Share by Countries (2015-2020)
Table 68. North America Tumor Necrosis Factor Receptor Superfamily Member 9 Revenue by Countries (2015-2020) (USD Million)
Table 69. North America Tumor Necrosis Factor Receptor Superfamily Member 9 Revenue Market Share by Countries (2015-2020)
Table 70. Europe Tumor Necrosis Factor Receptor Superfamily Member 9 Sales by Countries (2015-2020) (K Pcs)
Table 71. Europe Tumor Necrosis Factor Receptor Superfamily Member 9 Sales Market Share by Countries (2015-2020)
Table 72. Europe Tumor Necrosis Factor Receptor Superfamily Member 9 Revenue by Countries (2015-2020) (USD Million)
Table 73. Asia-Pacific Tumor Necrosis Factor Receptor Superfamily Member 9 Sales by Regions (2015-2020) (K Pcs)
Table 74. Asia-Pacific Tumor Necrosis Factor Receptor Superfamily Member 9 Sales Market Share by Regions (2015-2020)
Table 75. Asia-Pacific Tumor Necrosis Factor Receptor Superfamily Member 9 Revenue by Regions (2015-2020) (USD Million)
Table 76. South America Tumor Necrosis Factor Receptor Superfamily Member 9 Sales by Countries (2015-2020) (K Pcs)
Table 77. South America Tumor Necrosis Factor Receptor Superfamily Member 9 Sales Market Share by Countries (2015-2020)
Table 78. South America Tumor Necrosis Factor Receptor Superfamily Member 9 Revenue by Countries (2015-2020) (USD Million)
Table 79. South America Tumor Necrosis Factor Receptor Superfamily Member 9 Revenue Market Share by Countries (2015-2020)
Table 80. Middle East & Africa Tumor Necrosis Factor Receptor Superfamily Member 9 Sales by Countries (2015-2020) (K Pcs)
Table 81. Middle East & Africa Tumor Necrosis Factor Receptor Superfamily Member 9 Sales Market Share by Countries (2015-2020)
Table 82. Middle East & Africa Tumor Necrosis Factor Receptor Superfamily Member 9 Revenue by Countries (2015-2020) (USD Million)
Table 83. Middle East & Africa Tumor Necrosis Factor Receptor Superfamily Member 9 Revenue Market Share by Countries (2015-2020)
Table 84. Global Tumor Necrosis Factor Receptor Superfamily Member 9 Sales by Type (2015-2020) (K Pcs)
Table 85. Global Tumor Necrosis Factor Receptor Superfamily Member 9 Sales Share by Type (2015-2020)
Table 86. Global Tumor Necrosis Factor Receptor Superfamily Member 9 Revenue by Type (2015-2020) (USD Million)
Table 87. Global Tumor Necrosis Factor Receptor Superfamily Member 9 Revenue Share by Type (2015-2020)
Table 88. Global Tumor Necrosis Factor Receptor Superfamily Member 9 Sales by Application (2015-2020) (K Pcs)
Table 89. Global Tumor Necrosis Factor Receptor Superfamily Member 9 Sales Share by Application (2015-2020)
Table 90. Global Tumor Necrosis Factor Receptor Superfamily Member 9 Sales Forecast by Regions (2021-2025) (K Pcs)
Table 91. Global Tumor Necrosis Factor Receptor Superfamily Member 9 Market Share Forecast by Regions (2021-2025)
Table 92. Global Tumor Necrosis Factor Receptor Superfamily Member 9 Sales Forecast by Type (2021-2025) (K Pcs)
Table 93. Global Tumor Necrosis Factor Receptor Superfamily Member 9 Market Share Forecast by Type (2021-2025)
Table 94. Global Tumor Necrosis Factor Receptor Superfamily Member 9 Sales Forecast by Application (2021-2025)
Table 95. Global Tumor Necrosis Factor Receptor Superfamily Member 9 Market Share Forecast by Application (2021-2025)
Table 96. Direct Channel Pros & Cons
Table 97. Indirect Channel Pros & Cons
Table 98. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Tumor Necrosis Factor Receptor Superfamily Member 9 Picture
Figure 2. Global Sales Market Share of Tumor Necrosis Factor Receptor Superfamily Member 9 by Type in 2019
Figure 3. Ultra-41BBL Picture
Figure 4. PRS-342 Picture
Figure 5. ISAS-01 Picture
Figure 6. EU-101 Picture
Figure 7. Others Picture
Figure 8. Tumor Necrosis Factor Receptor Superfamily Member 9 Sales Market Share by Application in 2018
Figure 9. Gastric Cancer Picture
Figure 10. Bladder Cancer Picture
Figure 11. Cervical Cancer Picture
Figure 12. Lymphoma Picture
Figure 13. Others Picture
Figure 14. Global Tumor Necrosis Factor Receptor Superfamily Member 9 Market Status and Outlook (2015-2025) (USD Million)
Figure 15. United States Tumor Necrosis Factor Receptor Superfamily Member 9 Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Canada Tumor Necrosis Factor Receptor Superfamily Member 9 Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Mexico Tumor Necrosis Factor Receptor Superfamily Member 9 Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Germany Tumor Necrosis Factor Receptor Superfamily Member 9 Revenue (Value) and Growth Rate (2015-2025)
Figure 19. France Tumor Necrosis Factor Receptor Superfamily Member 9 Revenue (Value) and Growth Rate (2015-2025)
Figure 20. UK Tumor Necrosis Factor Receptor Superfamily Member 9 Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Russia Tumor Necrosis Factor Receptor Superfamily Member 9 Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Italy Tumor Necrosis Factor Receptor Superfamily Member 9 Revenue (Value) and Growth Rate (2015-2025)
Figure 23. China Tumor Necrosis Factor Receptor Superfamily Member 9 Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Japan Tumor Necrosis Factor Receptor Superfamily Member 9 Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Korea Tumor Necrosis Factor Receptor Superfamily Member 9 Revenue (Value) and Growth Rate (2015-2025)
Figure 26. India Tumor Necrosis Factor Receptor Superfamily Member 9 Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Southeast Asia Tumor Necrosis Factor Receptor Superfamily Member 9 Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Australia Tumor Necrosis Factor Receptor Superfamily Member 9 Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 29. Brazil Tumor Necrosis Factor Receptor Superfamily Member 9 Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Egypt Tumor Necrosis Factor Receptor Superfamily Member 9 Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Saudi Arabia Tumor Necrosis Factor Receptor Superfamily Member 9 Revenue (Value) and Growth Rate (2015-2025)
Figure 32. South Africa Tumor Necrosis Factor Receptor Superfamily Member 9 Revenue (Value) and Growth Rate (2015-2025)
Figure 33. Turkey Tumor Necrosis Factor Receptor Superfamily Member 9 Revenue (Value) and Growth Rate (2015-2025)
Figure 34. Global Tumor Necrosis Factor Receptor Superfamily Member 9 Sales Market Share by Manufacturer in 2019
Figure 35. Global Tumor Necrosis Factor Receptor Superfamily Member 9 Revenue Market Share by Manufacturer in 2019
Figure 36. Top 3 Tumor Necrosis Factor Receptor Superfamily Member 9 Manufacturer (Revenue) Market Share in 2019
Figure 37. Top 6 Tumor Necrosis Factor Receptor Superfamily Member 9 Manufacturer (Revenue) Market Share in 2019
Figure 38. Key Manufacturer Market Share Trend
Figure 39. Global Tumor Necrosis Factor Receptor Superfamily Member 9 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 40. Global Tumor Necrosis Factor Receptor Superfamily Member 9 Revenue and Growth Rate (2015-2020) (USD Million)
Figure 41. Global Tumor Necrosis Factor Receptor Superfamily Member 9 Revenue Market Share by Regions (2015-2020)
Figure 42. Global Tumor Necrosis Factor Receptor Superfamily Member 9 Revenue Market Share by Regions in 2018
Figure 43. North America Tumor Necrosis Factor Receptor Superfamily Member 9 Sales and Growth Rate (2015-2020)
Figure 44. Europe Tumor Necrosis Factor Receptor Superfamily Member 9 Sales and Growth Rate (2015-2020)
Figure 45. Asia-Pacific Tumor Necrosis Factor Receptor Superfamily Member 9 Sales and Growth Rate (2015-2020)
Figure 46. South America Tumor Necrosis Factor Receptor Superfamily Member 9 Sales and Growth Rate (2015-2020)
Figure 47. Middle East & Africa Tumor Necrosis Factor Receptor Superfamily Member 9 Sales and Growth Rate (2015-2020)
Figure 48. North America Tumor Necrosis Factor Receptor Superfamily Member 9 Revenue and Growth Rate (2015-2020) (USD Million)
Figure 49. North America Tumor Necrosis Factor Receptor Superfamily Member 9 Sales Market Share by Countries (2015-2020)
Figure 50. North America Tumor Necrosis Factor Receptor Superfamily Member 9 Sales Market Share by Countries in 2018
Figure 51. North America Tumor Necrosis Factor Receptor Superfamily Member 9 Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 52. North America Tumor Necrosis Factor Receptor Superfamily Member 9 Revenue Market Share by Countries in 2018
Figure 53. United States Tumor Necrosis Factor Receptor Superfamily Member 9 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 54. Canada Tumor Necrosis Factor Receptor Superfamily Member 9 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 55. Mexico Tumor Necrosis Factor Receptor Superfamily Member 9 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 56. Europe Tumor Necrosis Factor Receptor Superfamily Member 9 Revenue and Growth Rate (2015-2020) (USD Million)
Figure 57. Europe Tumor Necrosis Factor Receptor Superfamily Member 9 Revenue Market Share by Countries (2015-2020)
Figure 58. Europe Tumor Necrosis Factor Receptor Superfamily Member 9 Revenue Market Share by Countries in 2019
Figure 59. Germany Tumor Necrosis Factor Receptor Superfamily Member 9 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 60. UK Tumor Necrosis Factor Receptor Superfamily Member 9 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 61. France Tumor Necrosis Factor Receptor Superfamily Member 9 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 62. Russia Tumor Necrosis Factor Receptor Superfamily Member 9 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 63. Italy Tumor Necrosis Factor Receptor Superfamily Member 9 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 64. Asia-Pacific Tumor Necrosis Factor Receptor Superfamily Member 9 Revenue and Growth Rate (2015-2020) (USD Million)
Figure 65. Asia-Pacific Tumor Necrosis Factor Receptor Superfamily Member 9 Sales Market Share by Regions 2019
Figure 66. Asia-Pacific Tumor Necrosis Factor Receptor Superfamily Member 9 Revenue Market Share by Regions 2019
Figure 67. China Tumor Necrosis Factor Receptor Superfamily Member 9 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 68. Japan Tumor Necrosis Factor Receptor Superfamily Member 9 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 69. Korea Tumor Necrosis Factor Receptor Superfamily Member 9 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 70. India Tumor Necrosis Factor Receptor Superfamily Member 9 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 71. Southeast Asia Tumor Necrosis Factor Receptor Superfamily Member 9 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 72. South America Tumor Necrosis Factor Receptor Superfamily Member 9 Revenue and Growth Rate (2015-2020) (USD Million)
Figure 73. South America Tumor Necrosis Factor Receptor Superfamily Member 9 Sales Market Share by Countries in 2019
Figure 74. South America Tumor Necrosis Factor Receptor Superfamily Member 9 Revenue Market Share by Countries in 2019
Figure 75. Brazil Tumor Necrosis Factor Receptor Superfamily Member 9 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 76. Argentina Tumor Necrosis Factor Receptor Superfamily Member 9 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 77. Middle East and Africa Tumor Necrosis Factor Receptor Superfamily Member 9 Revenue and Growth Rate (2015-2020) (USD Million)
Figure 78. Middle East and Africa Tumor Necrosis Factor Receptor Superfamily Member 9 Sales Market Share by Countries in 2019
Figure 79. Middle East and Africa Tumor Necrosis Factor Receptor Superfamily Member 9 Revenue Market Share by Countries (2015-2020)
Figure 80. Middle East and Africa Tumor Necrosis Factor Receptor Superfamily Member 9 Revenue Market Share by Countries in 2019
Figure 81. Saudi Arabia Tumor Necrosis Factor Receptor Superfamily Member 9 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 82. Egypt Tumor Necrosis Factor Receptor Superfamily Member 9 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 83. Turkey Tumor Necrosis Factor Receptor Superfamily Member 9 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 84. South Africa Tumor Necrosis Factor Receptor Superfamily Member 9 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 85. Global Tumor Necrosis Factor Receptor Superfamily Member 9 Sales and Growth Rate (2021-2025) (K Pcs)
Figure 86. Global Tumor Necrosis Factor Receptor Superfamily Member 9 Revenue and Growth Rate (2021-2025) (USD Million)
Figure 87. North America Sales Tumor Necrosis Factor Receptor Superfamily Member 9 Market Forecast (2021-2025) (K Pcs)
Figure 88. Europe Sales Tumor Necrosis Factor Receptor Superfamily Member 9 Market Forecast (2021-2025) (K Pcs)
Figure 89. Asia-Pacific Sales Tumor Necrosis Factor Receptor Superfamily Member 9 Market Forecast (2021-2025) (K Pcs)
Figure 90. South America Sales Tumor Necrosis Factor Receptor Superfamily Member 9 Market Forecast (2021-2025) (K Pcs)
Figure 91. Middle East & Africa Sales Tumor Necrosis Factor Receptor Superfamily Member 9 Market Forecast (2021-2025) (K Pcs)
Figure 92. Sales Channel: Direct Channel vs Indirect Channel
腫瘍壊死因子阻害薬の世界市場 2020年 Market Overview The global Tumor Necrosis Factor Inhibitors Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Tumor N…- NT 3成長因子受容体の世界市場 2020年 Market Overview The global NT 3 Growth Factor Receptor market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The NT 3 Growth Facto…
- 一過性受容体電位カチオンチャネルサブファミリーVメンバー1の世界市場 2020年 Market Overview The global Transient Receptor Potential Cation Channel Subfamily V Member 1 market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx m…
- 線維芽細胞成長因子受容体3の世界市場 2020年 Market Overview The global Fibroblast Growth Factor Receptor 3 market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Fibroblas…
- 線維芽細胞成長因子受容体4の世界市場 2020年 Market Overview The global Fibroblast Growth Factor Receptor 4 market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Fibroblas…